Predictions
Cellectis Nom.
Start price
Target price
Perf. (%)
€2.40
09.12.13
09.12.13
€2.70
09.06.14
09.06.14
175.00%
09.06.14
09.06.14
Could be worthwhile Investment >10% per year
ALK-Abelló A/S B
Start price
Target price
Perf. (%)
€5.39
22.05.14
22.05.14
€5.75
06.06.14
06.06.14
6.75%
06.06.14
06.06.14
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Clovis Oncology Inc.
Start price
Target price
Perf. (%)
€42.29
21.05.14
21.05.14
€36.20
29.05.14
29.05.14
-16.48%
29.05.14
29.05.14
Rigel Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€1.99
20.11.13
20.11.13
€2.20
20.05.14
20.05.14
20.77%
20.05.14
20.05.14
Could be worthwhile Investment >10% per year
Astellas Pharma Inc.
Start price
Target price
Perf. (%)
€45.42
17.11.13
17.11.13
€42.00
19.05.14
19.05.14
-81.45%
19.05.14
19.05.14
Valneva SE
Start price
Target price
Perf. (%)
€4.27
08.11.13
08.11.13
€5.50
08.05.14
08.05.14
40.05%
08.05.14
08.05.14
Could be worthwhile Investment >10% per year
Very valuable balance sheet
Viracta Therapeutics Inc.
Start price
Target price
Perf. (%)
€767.97
30.09.13
30.09.13
€945.00
31.03.14
31.03.14
24.17%
31.03.14
31.03.14
Vanda Pharmaceuticals
Start price
Target price
Perf. (%)
€8.80
11.09.13
11.09.13
€9.50
11.03.14
11.03.14
23.88%
11.03.14
11.03.14
Sangamo Therapeutics Inc.
Start price
Target price
Perf. (%)
€7.80
05.09.13
05.09.13
€8.50
05.03.14
05.03.14
75.65%
05.03.14
05.03.14
Organovo Holdings Inc.
Start price
Target price
Perf. (%)
€127.00
05.02.14
05.02.14
€151.00
21.02.14
21.02.14
19.02%
21.02.14
21.02.14
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€4.32
09.08.13
09.08.13
€5.00
10.02.14
10.02.14
55.25%
10.02.14
10.02.14
Rockwell Medical Inc.
Start price
Target price
Perf. (%)
€29.74
27.06.13
27.06.13
€33.00
27.12.13
27.12.13
198.74%
27.12.13
27.12.13